Can serum interleukin-17 and interleukin-10 levels predict response to biologic treatments in patients with rheumatoid arthritis?
Authors:
- Stephen McDonaldSMStephen McDonald
- Biologics in Rheumatoid Arthritis Genetics and Genomics Study SyndicateBSBiologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate
- Stephanie LingStephanie Ling
- 27 April 2019
- journal article
- letter
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 58 (10) , 1872-1873
Abstract
Rheumatology key message. IL-17 levels do not predict response/non-response to anti-TNF drugs.Keywords
Funding Information
- Manchester Molecular Pathology Node
- MMPathIC (MR/N00583X/1)
- National Institute for Health Research Manchester Biomedical Research Centre
- Arthritis Research UK (21754)
This publication has 2 references indexed in Scilit:
- Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the jointsScandinavian Journal of Rheumatology, 2009
- The role of interleukin-17 in the pathogenesis of rheumatoid arthritisCurrent Rheumatology Reports, 2009